BIOMAT Database Logo BIOMAT Database Logo

Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. 1996

A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
ORTON Research Institute, Orthopaedic Hospital, Invalid Foundation, Helsinki, Finland.

OBJECTIVE Von Willebrand factor (vWF) is an adhesive glycoprotein produced and secreted constitutively by endothelial cells. vWF is released upon endothelial stimulation and/or vascular injury, and mediates adhesion and aggregation of platelets. Our aim was to quantify synovial vasculature and to evaluate vWF distribution in situ in synovial membranes in various arthritides. METHODS Immunohistochemical staining of vWF in synovial membranes from patients with rheumatoid arthritis (RA) (N = 9), psoriatic (PsA) (N = 3), and reactive (ReA) (N = 4) arthritis, and from 6 noninflammatory controls: osteoarthritis (N = 1), chondromatosis (N = 1), meniscus lesion (N = 4). Morphometric assessments were performed with an image analyzer. RESULTS In RA, mean number of blood vessels/mm2 in the thickened synovium was relatively low (131 +/- 57 vs control 257 +/- 115, p = 0.0137, ReA 346 +/- 83, p = 0.0002, PsA 434 +/- 157, p = 0.0127). In particular, the superficial layer, corresponding to the thickness of normal synovial membrane (i.e., 56 +/- 5 microns), was sparsely vascularized (70 +/- 37 in the superficial vs 219 +/- 104 in the deeper layer, p = 0.0047). Synovial thickening was not seen in ReA and PsA. In accordance with its constitutive metabolism, vWF was found in the endothelial cells, inside the blood vessels, and in the subendothelium. In addition, RA was characterized by weak endothelial immunoreactivity and perivascular vWF. In ReA, perivascular vWF staining was visible in areas of inflammatory cell infiltrates. CONCLUSIONS Morphometric findings indicate decreased vascularization of the superficial synovial membrane in RA. Second, vWF may play a role in the inflammatory/reparative responses in synovium in RA and ReA, which were characterized by vascular stimulation/injury and abnormal vWF distribution.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000091402 Prohibitins Ubiquitously expressed conserved proteins associated with multiple functions including APOPTOSIS; CELL PROLIFERATION, regulations of various immune and mitochondrial functions, and cellular stress responses. Prohibitin 1 and prohibitin 2 form a ring-shaped complex in the INNER MITOCHONDRIAL MEMBRANE. Prohibitin

Related Publications

A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
von Willebrand factor in synovial fluid.
January 1991, Clinical and experimental rheumatology,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
Platelet membrane von Willebrand factor:.
October 1978, Blood,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
von Willebrand factor in synovial fluid: a comment.
January 1992, Clinical and experimental rheumatology,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.
July 2016, Blood,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
von Willebrand disease and von Willebrand factor.
May 2022, Haemophilia : the official journal of the World Federation of Hemophilia,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
Von Willebrand factor and von Willebrand disease.
December 2001, Reviews in clinical and experimental hematology,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
von Willebrand factor and von Willebrand disease.
October 1987, Blood,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
von Willebrand factor and von Willebrand disease.
January 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
[Von Willebrand factor and Von Willebrand disease].
January 2014, Nederlands tijdschrift voor geneeskunde,
A Ceponis, and Y T Konttinen, and Z MacKevicius, and S A Solovieva, and M Hukkanen, and M Tamulaitiene, and A Matulis, and S Santavirta
Exponential size distribution of von Willebrand factor.
September 2013, Biophysical journal,
Copied contents to your clipboard!